|
Federal Interagency Traumatic Brain Injury Research (FITBIR) Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIDA, NCATS, NHLBI, NIA, NIAAA, NIBIB, NICHD, NIDCD, NIGMS, NIMH, NINDS, OD
|
To encourage greater cross-talk and cross-agency collaboration through enhanced information exchange opportunities on TBI related issues, especially best practices. Specifically, the committee''s charge is fourfold: 1) create and contribute to a centralized online clearinghouse of Federal resources pertaining to TBI; 2) share information regarding upcoming agency events related to TBI; 3) review program strategic plans, materials and funding opportunities to facilitate collaboration, minimize duplication of efforts and fill service gaps; 4) develop and disseminate media to build awareness and promote greater visibility of TBI and associated Federal programs.
|
|
Federal Interagency Workgroup on Child Abuse and Neglect
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AoA, CDC, HRSA, IHS, OS, SAMHSA
|
OD, NICHD, NIDA, NIMH
|
Multi-agency workgroup designed to share information hand pool resources on child abuse and neglect
|
|
Federal Interagency Workgroup on Teen Dating Violence (TDV)
|
Research Initiative
|
ACF, CDC, HRSA, OS, SAMHSA
|
NICHD, NIAAA, NIDA, NIMH, NIMHD, OD
|
The federal government is coordinating efforts to address the problem of teen dating violence through this workgroup, which serves as a forum for information sharing, cooperation, and collaboration.
|
|
Federal Interagency Working Group on Vitamin D
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, OS
|
NEI, NCCAM, NCI, NHLBI, NIA, NIAMS, NICHD, NIDDK, NIEHS, NIMHD, OD
|
The Federal Working Group on Vitamin D is focused on the development of a comprehensive and forward-looking research agenda for vitamin D.
|
|
Federal Interagency Working Group on Women''s Health and the Environment
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD, NCI, NIEHS
|
This committee consists of representatives from various federal agencies and offices. The committee''s three main goals are: (1) to discuss and exchange information on ongoing activities in research, information dissemination and outreach, health care services, training, and public policy related to women''s health and the environment, (2) to ensure cooperation and consolidation of efforts between the various federal agencies and offices that work on the issue of women''s health and the environment, (3) to identify gaps, foster collaborations between agencies, and plan and implement activities that address identified needs.
|
|
Federal Investigator Registry of Biomedical Information Research (FIREBIRD)
|
Resource Development
|
FDA
|
NCI
|
An agreement has been reached by the FDA and the NCI to manage and share information about clinical investigators using the Federal Investigator Registry of Biomedical Information Research Data, or FIREBIRD, system. Drug makers are encouraged to also submit information about investigators electronically to the new registry. FIREBIRD is the first module of an expected suite of software programs that will comprise a system called the Clinical Research Information Exchange (CRIX). CRIX is intended to support the biomedical and biopharmaceutical research community by streamlining the document and data exchange process. The resulting reduction of paperwork is expected to increase the efficiency and lower the cost of conducting clinical trials.
|
|
Federal Liaison Group on Asthma (FLGA)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS
|
NIAID, NHLBI, NIEHS, NIMH, NINR, NLM
|
The FLGA is committed to achieving and maintaining effective coordination that respects the unique contributions of individual agencies, facilitates exchange of information to avoid duplication, enables identification of opportunities for collaboration, and ensures that consistent messages about asthma are developed and disseminated. Much coordination of federal asthma activities already exists, and plans for expansion are under way. The FLGA will continue to explore current and planned asthma activities in greater depth in each of the five goal areas and seek new opportunities for interagency coordination and collaboration.
|
|
Federal mHealth Collaborative
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
OD, NCI, NICHD, NIDA
|
Federal working group of agencies interested in mHealth technology and its potential for enhancing health care
|
|
Federal Partners in Bullying Prevention, Intervention, and Recovery
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, HRSA, IHS, SAMHSA
|
NIMH, NIAAA, NICHD, NIDA, OD
|
This workgroup meets to provide a forum through which staff from relevant Federal agencies can communicate and exchange ideas concerning how to prevent or stop bullying in schools and communities.
|
|
Federal Partners in the Gulf Long-Term Follow-up (GuLF) Study Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ATSDR, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
OD/DPCPSI, CIT, NHGRI, NIEHS, NIMH, NLM, OD
|
The Federal Partners in the Gulf Long-Term Follow-up (GuLF) Study Working Group is an interagency group of Federal agencies responding to potential health effects of the Deepwater Horizon oil spill disaster. The working group was convened to provide input on the design and conduct of the Gulf Long-Term Follow-up (GuLF) study, a longitudinal study of oil spill clean-up workers led by the National Institute of Environmental Health Sciences with support from the NIH Common Fund, NIH OD and BP. Working group members share ideas on ways to maximize interagency efficiency and effectiveness by working collaboratively on areas of common interest and sharing data and samples collected by their agencies, they identify data collection needs that could be met by the GuLF study rather than duplicate surveys to the same population, and they identify agency resources that could be brought together to improve the GuLF study. Scientific oversight for the study is provided by the National Academy of Science''s Institute of Medicine.
This helps to facilitate information exchange and coordination among federal agencies with regards to understanding the toxicity and health effects associated with the of Gulf oil spill exposures among workers and affected communities.
|